Latest Equity Capital Raises News

PYC Therapeutics has initiated a substantial capital raising effort, aiming to secure up to A$653 million to propel its four RNA therapeutic candidates through critical clinical milestones. The retail entitlement offer opens today, following a successful institutional placement.

Cyclopharm Limited is accelerating its US market push for Technegas with a A$16 million capital raise following a record 2025 sales performance. The company aims to expand its US installations and advance new clinical applications beyond pulmonary embolism.

Mount Hope Mining (MHM) showcased strong drilling outcomes at its Mt Solitary gold project, reinforcing its strategic foothold in the prolific southern Cobar Basin. The company is advancing exploration with a clear pathway to resource definition and regional consolidation.

PYC Therapeutics has launched a substantial $653 million equity raise to fund clinical trials for four promising drug candidates targeting genetic diseases. This capital injection aims to advance the company’s pipeline through critical human efficacy milestones.

Alpha HPA Limited reports strong progress on its HPA First Project Stage 2 construction and secures binding supply contracts for 2026 in the booming semiconductor sector, while launching a $225 million equity raise to fund expansion.

Wisr Limited has reported a robust Q2FY26 with a 23% jump in its loan book and a 16% revenue increase, underpinned by a surge in loan originations and improved credit metrics. The fintech lender also strengthened its balance sheet through a capital raise and debt refinancing, setting the stage for profitability later this year.

Tlou Energy Limited reported a challenging quarter with net cash outflows but secured financing and is actively seeking additional funds to sustain its operations and development plans.

Canadian Phosphate Limited has improved its operating cash flow and strengthened its balance sheet through a successful capital raise and asset sale, while advancing key permits and strategic partnerships for its Canadian phosphate projects.

A takeover premium blew the doors off the Materials board this week, while one discounted equity raise did the opposite. Uranium names kept climbing on real production progress, and rare earths stayed in favour as governments and buyers circle supply.

A takeover offer lit up small caps, while one high-growth software name slid hard despite strong sector news. Resources dominated the winners list, but investors still punished dilution and discounted fundraisings.

VRX Silica Limited has locked in six binding offtake contracts totaling nearly 1 million tonnes per annum and appointed a new CEO, marking significant progress for its Arrowsmith North silica sand project.

JAYRIDE Group has amended its quarterly cash flow report to correct classification errors, while outlining plans for a new SaaS platform rollout and potential capital raising to support operations.